Editorial: direct-acting antivirals decrease the frequency of diabetes complications in patients with chronic hepatitis C

Aliment Pharmacol Ther. 2019 Apr;49(8):1094-1095. doi: 10.1111/apt.15152.

Benjamin Buchard¹, Patrice Cacoub^{2

3

4

5}, Bruno Pereira⁶, Armand Abergel^{1

7}

¹ Service de médecine digestive et hépatobiliaire, CHU Clermont Ferrand, Clermont Ferrand, France.
² Sorbonne Universités, UPMC Univ Paris 06, UMR 7211, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France.
³ INSERM, UMR_S 959, Paris, France.
⁴ CNRS, FRE3632, Paris, France.
⁵ Department of Internal Medicine and Clinical Immunology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
⁶ Délégation à la Recherche Clinique et à l'innovation, Clermont Ferrand, France.
⁷ UMR 6602 UCA CNRS SIGMA, Clermont Ferrand, France.

No abstract available

Publication types